Top

Published in:

01-05-2016

Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes

Authors: David S. Poch, William R. Auger

Published in: Heart Failure Reviews | Issue 3/2016

Abstract

Pulmonary hypertension due to chronic thromboembolic disease is potentially curable with pulmonary thromboendarterectomy surgery. As a result, it is important for clinicians to recognize and appropriately diagnose this form of pulmonary hypertension. Advances in this field with changes in surgical technique, the availability of PH-targeted medical therapy for select patient subgroups, and the development of balloon pulmonary angioplasty have broadened therapeutic options for patients. This review will examine what is known about the epidemiology and medical conditions placing patients at risk of developing this disease, will present an approach to evaluation of patients with suspected chronic thromboembolic disease, and will describe the surgical and non-surgical management of this unique patient population.

Daily PO, Auger WR (1999) Historical perspective: surgery for chronic thromboembolic disease. Sem Thorac Cardiovasc Surg 11(2):143–151CrossRef

Pepke-Zaba J, Hoeper MM, Humbert M (2013) Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Resp J 41:8–9CrossRef

Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41CrossRefPubMed

Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124:1973–1981CrossRefPubMed

Pengo V, Lensing ASA, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264CrossRefPubMed

Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, Dainelli A, Giuntini C (2006) Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine 85:253–262CrossRefPubMed

Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130:172–175CrossRefPubMed

Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124:256–258CrossRefPubMed

Klok FA, van Kralingen KW, van Dijk APJ, Heyning FH, Vliegen HW (2010) Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acutepulmonary embolism. Haematologica 95:970–975CrossRefPubMedPubMedCentral

10.

Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y (2012) Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost 18:281–288CrossRefPubMed

11.

Guerin L, Couturaud F, Parent F et al (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 112:598–605CrossRefPubMed

12.

Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, Kneussl M, Rubun LJ, Kyrle PA, Klepetko W, Maurer G, Lang IM (2003) High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 90:372–376PubMed

13.

Wong CL, Szydio R, Gibbs S, Laffan M (2010) Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 21:201–206CrossRefPubMed

14.

Bonderman D, Wilkens H, Wakounig S, Schafers H-J, Jansa P, Linder J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Resp J 33:325–331CrossRef

15.

O’Donnell J, Laffan MA (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11:343–351CrossRefPubMed

16.

Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H (2007) Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 92:3006–3012CrossRefPubMed

17.

Lang IM, Pesavento R, Bonderman D, Yuan JX-J (2013) Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Resp J 41:462–468CrossRef

18.

Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M (2015) Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Resp J 46:431–443CrossRef

19.

Bernard J, Yi ES (2007) Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol 38:871–877CrossRefPubMed

20.

Wynants M, Quarck R, Ronisz A, Alfaro-Moreno E, Van Raemdonck D, Meyns B, Delcroix M (2012) Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Resp J 40:886–894CrossRef

21.

Morris TA, Marsh JJ, Chiles PG, Magana MM, Liang NC, Soler X, Desantis DJ, Ngo D, Woods VL Jr (2009) High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 114:1929–1936CrossRefPubMedPubMedCentral

22.

Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, Balint Z, Olschewski A (2012) Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One 7(8):e43793CrossRefPubMedPubMedCentral

23.

Sakao S, Hao H, Tanabe N, Kasahara Y, Kurosu K, Tatsumi K (2011) Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells. Resp Res 12:109CrossRef

24.

Firth AL, Yao W, Ogawa A, Madani MM, Lin GY, Yuan JX (2010) Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol 298:C1217–C1225CrossRefPubMedPubMedCentral

25.

Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103:685–692CrossRefPubMed

26.

Dorfmūller P, Gūnther S, Ghigna M-R, de Montpréville BoulateD, Paul J-F, Jaïs X, Decante B, Simonneau G, Darteville P, Humbert M, Fadel E, Mercier O (2014) Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Resp J 44(5):1275–1288CrossRef

27.

McCann C, Gopalan D, Sheares K, Screaton N (2012) Imaging in pulmonary hypertension, part 2: large vessel diseases. Postgrad Med J 88:317–325CrossRefPubMed

28.

Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM (1996) Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 110:399–403CrossRefPubMed

29.

Steenhuis LH, Groen HJM, Koeter GH, van der Mark TW (2000) Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 16:276–281CrossRefPubMed

30.

Kapitan KS, Buchbinder M, Wagner PD, Moser KM (1989) Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 139:1149–1154CrossRefPubMed

31.

Held M, Grün M, Kaiser R, Wilkens H, Jany BH (2014) Cardiopulmonary exercise testing to detect pulmonary hypertension in patients with suspected chronic thromboembolic pulmonary hypertension and normal echocardiography. Respiration 87:379–387PubMed

32.

Held M, Hesse A, Gött F et al (2014) A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study. Pulm Med 14:141–148CrossRef

33.

Raisinghani A, Ben-Yehuda O (2006) Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 18:230–235CrossRefPubMed

34.

Blanchard DG, Malouf PJ, Gurudevan SV et al (2009) Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolicpulmonary hypertension before and after pulmonary thromboendarterectomy. JACC Cardiovasc Imaging 2(2):143–149CrossRefPubMed

35.

Xie Y, Burke BM, Kopelnik A et al (2014) Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart doppler measurements. Echocardiography 31:29–33CrossRefPubMed

36.

Marston N, Brown JP, Olson N et al (2015) Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Echocardiography 32:1115–1121CrossRefPubMed

37.

Kim NH, Delcroix M, Jenkins DP, Channick R, Darteville P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E (2013) Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 62:D92–D99CrossRefPubMed

38.

Tunariu N, Gibbs SJ, Win Z, Gin-Sing W, Graham A, Gishen P, Al-Nahhas A (2007) Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic disease as a treatable cause of pulmonary hypertension. J Nucl Med 48:680–684CrossRefPubMed

39.

He J, Fang W, Lv B, He JG, Xiong CM, Liu ZH, He ZX (2012) Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography. Nucl Med Commun 33(5):459–463CrossRefPubMed

40.

Sugiura T, Tanabe N, Matsuura Y, Shigeta A, Kawata N, Jujo T, Yanagawa N, Sakao S, Kasahara Y, Tatsumi K (2013) Role of 320-slice computed tomography in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension. Chest 143:1070–1077CrossRefPubMed

41.

Lisbona R, Kreisman H, Novales-Diaz J, Derbekyan V (1985) Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. Am J Roentgenol 144:27–30CrossRef

42.

Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730CrossRefPubMed

43.

Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM (1998) Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 93:1180–1185CrossRef

44.

Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES, Moser KM (1995) Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 152:367–373CrossRefPubMed

45.

Rossi SE, McAdams HP, Rosado-de-Christenson ML, Franks TJ, Galvin JR (2001) Fibrosing mediastinitis. Radiographics 21:737–757CrossRefPubMed

46.

Kerr KM (2005) Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonary hypertension. Nat Clin Pract Cardiovasc Med 2:108–112CrossRefPubMed

47.

Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL (1992) Chronic major- vessel chronic thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 183:393–398CrossRef

48.

Wijesuriya S, Chandratreya L, Medford AR (2013) Chronic pulmonary emboli and radiologic mimics on CT pulmonary angiography. A diagnostic challenge. Chest 143:1460–1471CrossRefPubMed

49.

Doǧan H, de Roos A, Geleijins J, Huisman MV, Kroft LJM (2015) The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol 21:307–316CrossRefPubMedPubMedCentral

50.

Willemink MJ, van Es HW, Koobs L, Morshuis WJ, Snijder RJ, van Heesewijk JPM (2012) CT evaluation of chronic thromboembolic pulmonary hypertension. Clin Radiol 67:277–285CrossRefPubMed

51.

McKie SJ, Hardwick DJ, Reid JH, Murchison JT (2005) Features of cardiac disease demonstrated on CT angiography. Clin Radiol 60:31–38CrossRefPubMed

52.

Lee NS, Blanchard DG, Knowlton KU, McDivitt AM, Pretorius V, Madani MM, Fedullo PF, Kerr KM, Kim NH, Poch DS, Auger WR, Daniels LB (2015) Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension. Pulm Circ 5(2):313–321CrossRefPubMedPubMedCentral

53.

Dournes G, Verdier D, Montaudon M et al (2014) Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol 24:42–51CrossRefPubMed

54.

Meinel FG, Graef A, Thierfelder KM et al (2013) Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension. Rofo 186:151–156CrossRefPubMed

55.

Grgic A, Miodek F, Schäfers H-J et al (2016) Assessment of operability by means of CTPA and perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension. Acta Radiol 57(1):33–40CrossRefPubMed

56.

Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, Duber C, Kreitner K-F (2012) Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 22:607–616CrossRefPubMed

57.

Nikolaou K, Schoenberg SO, Attenberger U, Scheidler J, Dietrich O, Kuehn B, Rosa F, Huber A, Leuchte H, Baumgartner R, Behr J, Reiser MF (2005) Pulmonary arterial hypertension: diagnosis with fast perfusion imaging and high-spatial- resolution MR angiography—preliminary experience. Radiology 236:694–703CrossRefPubMed

58.

Rajaram S, Swift AJ, Capener D, Telfer A et al (2013) 3D contrast-enhanced ling perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 68:677–678CrossRefPubMed

59.

Rolf A, Rixe J, Kim WK et al (2014) Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy—a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:96CrossRefPubMedPubMedCentral

60.

Fukui S, Ogo T, Morita Y et al (2014) Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 43:1394–1402CrossRefPubMed

61.

Kreitner K-F, Ley S, Kauczor H-U, Mayer E, Kramm T, Pitton MB, Krummenauer F, Thelen M (2004) Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold magnetic resonance techniques. Radiology 32:535–543CrossRef

62.

Claessen G, La Gerche A, Dymarkowski S et al (2015) Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. J Am Heart Assoc 4(3):e001601–e001602. doi:10.1161/JAHA.114.001602 CrossRef

63.

Ohno Y, Koyama H, Yoshikawa T et al (2012) Contrast-enhanced multidetector-row computed tomography vs. time-resolved magnetic resonance angiography vs. contrast-enhanced perfusion MRI: assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging 36:612–623CrossRefPubMed

64.

Ota H, Sugimura K, Miura M, Shimokawa H (2015) Four-dimensional flow magnetic resonance imaging visualizes drastic change in vortex flow in the main pulmonary artery after percutaneous transluminal pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Eur Heart J 36(25):1630. doi:10.1093/eurheartj/ehv054 CrossRefPubMed

65.

Fenster BE, Browning J, Schroeder JD et al (2015) Vorticity is a marker of right ventricular diastolic dysfunction. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00278.2015 PubMed

66.

Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NK, Fedullo PF, Jamieson SW (2012) Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2700 patients. Ann Thorac Surg 94:97–103CrossRefPubMed

67.

Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, Ilkjaer LB, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Darteville P (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141:702–710CrossRefPubMed

68.

de Perrot M, Thenganatt J, McRae K, Moric J, Mercier O, Pierre A, Mak S, Granton J (2015) Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 34:369–375CrossRefPubMed

69.

Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, Toshner M, Dunning JJ, Ng C, Tsui SS, Sheares KK (2014) Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Resp J 44(6):1635–1645CrossRef

70.

van der Plas MN, Reesink HJ, Roos CM (2010) Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation. Ann Thorac Surg 89:347–352CrossRefPubMed

71.

Berman M, Hardman G, Sharples L, Pepke-Zaba J, Sheares K, Tsui S, Dunning J, Jenkins DP (2012) Pulmonary endarterectomy: outcomes in patients aged >70. Eur J Cardio-Thorac Surg 41:e154–e160CrossRef

72.

Fernandes TM, Auger WR, Fedullo PF, Kim NH, Poch DS, Madani MM, Pretorius VG, Jamieson SW, Kerr KM (2014) Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy. Ann Thorac Surg 98:1776–1781CrossRefPubMedPubMedCentral

73.

Madani MM, Jamieson SW (2006) Technical advances of pulmonary endarterectomy for chronic thromboembolic disease. Semin Cardiovasc Thorac Surg 18:243–249CrossRef

74.

Freed DH, Thomson BM, Berman M, Tsui SSL, Dunning J, Sheares KK, Pepke-Zaba J, Jenkins DP (2011) Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 141:383–387CrossRefPubMed

75.

Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ (2009) Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg 35:947–952. doi:10.1016/j.ejcts.2009.01.023 (discussion 952) CrossRefPubMed

76.

Rahnavardi M, Yan TD, Cao C, Vallely MP, Bannon PG, Wilson MK (2011) Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. Ann Thorac Cardiovasc Surg 17:435–445CrossRefPubMed

77.

Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SSL, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177:1122–1127CrossRefPubMed

78.

Corsico AG, D’Armini AM, Cerveri I, Klersy C, Ansaldo E, Niniano R, Gatto E, Monterosso C, Morsolini M, Nicolardi S, Tramontin C, Pozzi E, Vigano M (2008) Long term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 178:419–424CrossRefPubMed

79.

D’Armini AM, Morsolini M, Mattiucci G, Grazioli V, Pin M, Valentini A, Silvaggio G, Klersy C, Dore R (2014) Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 148(3):1005–1011CrossRefPubMed

80.

Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM (2007) Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 115:2153–2158CrossRefPubMed

81.

Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW (2006) Outcomes of pulmonary thromboendarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 131:307–313CrossRefPubMed

82.

Bresser P, Pepke-Zaba J, Jaïs X, Humbert M, Hoeper MM (2006) Medical therapies for chronic thromboembolic pulmonary hypertension. An evolving paradigm. Proc Am Thorac Soc 3:594–600CrossRefPubMed

83.

Ghofrani HA, D’Armini AM, Grimminger F, Hoeper MM, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319–329CrossRefPubMed

84.

Simonneau G, D’Armini AM, Ghofrani H-A, Grimminger F, Hoeper MM, Jansa P, Kim NH, Wang C, Wilkins M, Fritsch A, Davie N, Colorado P, Mayer E (2015) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: along-term extension study (CHEST-2). Eur Respir J 45:1293–1302CrossRefPubMed

85.

Jais X, D’Armini A, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zapa J, Perchenet L, Morganti A, Simonneau G, Rubin LJ (2008) Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 52:2127–2134CrossRefPubMed

86.

Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, Sheares KK, Hughes R, Morrell NW, Pepke-Zaba J (2008) Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134:229–236CrossRefPubMed

87.

Cabrol S, Souza R, Jais X, Fadel E, Ali RHS, Humbert M, Darteville P, Simonneau G, Sitbon O (2007) Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 26:357–362CrossRefPubMed

88.

Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ (2008) Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 76:154–159CrossRefPubMed

89.

Skoro-Sajer N, Bonderman D, Wiesbauer F, Harja E, Jakowitsch J, Klepetko W, Kneussl MP, Lang IM (2007) Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 5:483–489CrossRefPubMed

90.

Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR (2009) Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 120:1248–1254CrossRefPubMed

91.

Voorburg JAI, Cats VM, Buis B, Bruschke AVG (1988) Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 94:1249–1253CrossRefPubMed

92.

Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ (2001) Balloon angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103:10–13CrossRefPubMed

93.

Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:748–755CrossRefPubMed

94.

Katoaka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, Tamura Y, Ando M, Fukuda K, Yoshino H, Satoh T (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762CrossRef

95.

Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, Tatebe S, Miyamichi-Yamamoto S, Shimokawa H (2012) Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 76:485–488CrossRefPubMed

96.

Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R (2013) Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 99:1415–1420CrossRefPubMed

97.

Inami T, Kataoka M, Shimura N, Ishiguro H, Yanagisawa R, Taguchi H, Fukuda K, Yoshino H, Satoh T (2013) Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 7:725–736CrossRef

98.

Taniguchi Y, Miyagawa K, Nakayama K, Kinutani H, Shinke T, Okada K, Okita Y, Hirata KI, Emoto N (2014) Ballon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. Eurointervention 10:518–525CrossRefPubMed

99.

Shimura N, Kataoka M, Inami T, Yanagisawa R, Ishiguro H, Kawakami T, Higuchi Y, Ando M, Fukuda K, Yoshino H, Satoh T (2015) Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol 183:138–142CrossRefPubMed

Title: Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes
Authors: David S. Poch
William R. Auger
Publication date: 01-05-2016
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 3/2016
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-015-9518-3

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

The right ventricle and pulmonary hypertension

Medical therapies for pulmonary arterial hypertension

Pulmonary hypertension associated with lung diseases and hypoxemia

Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction

Definition, epidemiology and registries of pulmonary hypertension

Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page